Join YipitData’s Katie Tang and Steve Tao as they introduce YipitData’s MedTech coverage through a look into the performance of Shockwave (SWAV).
The team will discuss:
-
How is US Revenue trending in 1Q24 so far?
-
Is SWAV’s Coronary segment continuing to expand?
-
How is C2+ adoption trending?
-
What have the effects of Aetna’s pre-authorization headwinds been on the Peripheral segment?
Audience Q&A – submit your questions in advance and we will make sure they are answered.
Speakers
<img class="thumb-image" elementtiming="system-gallery-block-grid" data-image="https://images.squarespace-cdn.com/content/v1/61a5868fbaa6ba287e749ca1/1704730748522-MC9HVR8KLTRMC4ETFZMZ/Katie+Tang+%7C+Product+Expert+Manager.jpg" data-image-dimensions="250×250" data-image-focal-point="0.5,0.5" alt="Katie Tang Senior Research Analyst
View Original Article